Dr Luke Mclean
Senior Research Fellow
Department of Medicine
29 Scholarly works
0 Projects
HIGHLIGHTS
2026
Journal article
Extended follow-up outcomes of patients with advanced cutaneous squamous cell carcinoma treated with cemiplimab on EMPOWER-CSCC-1: A retrospective cohort study
DOI: 10.1016/j.jaad.2025.11.0802026
Journal article
BRAF-targeted therapy in non-melanomatous BRAF-mutant tumours: a systematic review of broad but histology-modulated efficacy
DOI: 10.1007/s10147-026-03079-y2025
Journal article
Medical Oncology Group of Australia Incorporated Annual Scientific Meeting Program and Abstracts 12th-14th August 2025.
DOI: 10.1111/ajco.700082025
Journal article
Cemiplimab in the treatment of cutaneous squamous cell carcinoma
DOI: 10.1080/1750743X.2026.26196582025
Journal article
The evolving role of immune checkpoint inhibitors in cutaneous squamous cell carcinoma: Across the disease spectrum
DOI: 10.1016/j.ejcskn.2025.1007672025
Thesis / Dissertation
Understanding treatment outcomes to immune-checkpoint inhibitors in patients with non-melanomatous skin cancers
2024
Journal article
Assessment of perineural spread in advanced cutaneous squamous cell carcinomas treated with immunotherapy
DOI: 10.1186/s40644-024-00678-8
RECENT SCHOLARLY WORKS
2024
Journal article
A Retrospective Review and Comprehensive Tumour Profiling of Advanced Non-Melanomatous Cutaneous Spindle Cell Neoplasms Treated with Immune-Checkpoint Inhibitors
DOI: 10.3390/cancers160814522024
Conference Proceedings
Immunotherapy in advanced cutaneous non-melanomatous spindle cell neoplasms
DOI: 10.1158/1538-7445.AM2024-50942024
Journal article
Real-World Experience of Immune-Checkpoint Inhibitors in Older Patients with Advanced Cutaneous Squamous Cell Carcinoma
DOI: 10.1007/s40266-024-01095-z